Optima Health trading 'in line' as it continues to grow UK and Ireland platform
Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N) said full-year revenue rose around 15% to approximately £121 million for the year ended 31 March 2026, in line with market expectations, as the occupational health and wellbeing services provider continued to grow its UK and Ireland platform. The AIM-listed group said adjusted EBITDA for FY26 is expected to be around 10% ahead of previous market expectations, as previously announced.
Union Jack Oil reveals takeover approach by Reabold Resources
Union Jack Oil PLC (AIM:UJO, OTCQB:UJOGF, FRA:1UJ0) announced it has received a non-binding approach from Reabold Resources PLC (AIM:RBD, FRA:AWL1) over a possible all-share takeover. The AIM-listed oil and gas company said Reabold sent an indicative offer letter on 1 June 2026 covering a possible offer for Union Jack's entire issued share capital.
Poolbeg Pharma shows clinical progress with latest updates
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) said it has activated the first clinical site for its first-in-patient POLB 001 TOPICAL trial, moving its lead cancer immunotherapy programme into patient recruitment as interim data remains on track for summer 2026. The AIM-listed company said the trial is assessing POLB 001 as a potential preventative for cytokine release syndrome, or CRS, in around 30 relapsed/refractory multiple myeloma patients receiving the approved bispecific antibody teclistamab.
PAF raises £800,000 to advance Zimbabwe lithium project
Premier African Minerals Ltd (AIM:PREM, OTC:PRMMF) shares oscillated between a 4% rise and a 14% loss after the company raised £800,000 to support ongoing work at its Zulu lithium and tantalum project in Zimbabwe. The AIM-listed miner said it had completed a subscription for 4 billion new shares at 0.02p each, with the proceeds earmarked for operational activities at Zulu and general working capital.
Coastal Africa joins AIM with BP topping up £27m coffers
Coastal Africa Group Ltd (AIM:CAGL) arrived to a warm AIM welcome on Wednesday with £27 million of fresh capital, backing from BP PLC (LSE:BP.) and a promise to hunt for oil and gas assets across West Africa.
Coiled Therapeutics strengthens its scientific bench
Coiled Therapeutics (AIM:COIL, OTCQB:COTXF) has strengthened the scientific bench behind its lead cancer drug candidate AO-252, appointing Professor Ozgur Sahin as scientific advisor as the programme approaches a series of clinical milestones. The AIM-listed oncology company said Sahin, a named inventor on foundational patents underpinning AO-252, is one of the world's leading authorities on TACC3 biology.
AIM ImmunoTech Inc. (AIM) Discusses Ampligen's Potential Role in Addressing BundiBugyo Ebola Outbreak Transcript
AIM ImmunoTech Inc. (AIM) Discusses Ampligen's Potential Role in Addressing BundiBugyo Ebola Outbreak Transcript
The Hour-Long Project We Never Would've Started
By Andrew Rice, Partner and Portfolio Manager We may often come off as skeptical about AI in our newsletter. Our skepticism is primarily centered on the AI capital spend and AI company valuations rather than the AI tools themselves, which we have found both useful and exciting.
Creo Medical Group to raise £5.5m and advance partial divestment
Creo Medical Group PLC (AIM:CREO, FRA:1RC, OTC:CMEOF) announced plans to raise approximately £5.5 million through a placing as the medical device company moves to strengthen its balance sheet while pursuing the sale of its remaining stake in Creo Medical Europe. The AIM-listed group said it intends to issue around 36.7 million new shares at 15p each, a 31.9% premium to Thursday's closing mid-market price of 11.4p.
88 Energy says Augusta-1 exploration well is on track for Q1 2027
88 Energy Ltd (AIM:88E, ASX:88E, OTCQB:EEENF, FRA:POQ) has told investors that its planned Augusta-1 exploration well at South Prudhoe on Alaska's North Slope remains on track for a first-quarter 2027 spud, as the company advances permitting, logistics and farm-out discussions. The AIM and ASX-listed explorer said Augusta-1 is designed to test up to 133.7 million barrels of gross unrisked 2U prospective resources, or 111.4 million barrels net to 88 Energy, across stacked Ivishak, Kuparuk and Brookian reservoir targets.
Europa Oil & Gas drops as North Yorkshire refuses planning for potential gas drilling
Europa Oil & Gas (Holdings) Plc (AIM:EOG, FRA:EGN) shares fell 8.3% to 1.33p after North Yorkshire Council refused planning permission for the Cloughton gas appraisal well in North Yorkshire. The AIM-listed oil and gas group said the decision went against the recommendation of the council's own planning officers, who had advised the local planning authority to approve the application following reviews by 13 independent experts.
Sintana Energy raises $11.5m to support exploration plans in Namibia
Sintana Energy Inc (TSX-V:SEI, OTCQB:SEUSF, FRA:3ZX1, AIM:SEI) has conditionally raised US$11.5 million to back a busy exploration programme, including drilling on the Chevron-operated Nabba-1 well in Namibia's PEL 90. The fundraise was priced at 22.5p per new common share on AIM and C$0.41 on the TSX-V, with the company set to issue 38.0 million new shares.
